Barbara Burtness

28PUBLICATIONS
203CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyPhycology (incl. marine grasses)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jul 30, 2026
Combination AURKA and WEE1 inhibition exhibits efficacy in EGFR or pan-ERBB inhibitor resistant head and neck squamous cell carcinoma.

|May 31, 2026
Amivantamab in Recurrent/Metastatic Head and Neck Squamous Cell Cancer After Checkpoint Inhibitor and Chemotherapy: Pivotal Results From the Phase Ib/II OrigAMI-4 Study.

|Apr 20, 2026
Quantification of Antibody-Drug Conjugate Targets in Head and Neck Squamous Cell Carcinoma.

|Apr 01, 2026
Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer.

Sri Vemulamanda, Aditi Kothari, Loris De Cecco

|Mar 13, 2026
A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950).

Aarti Bhatia, Zhengjia Chen, Yuji Zhang

|Jan 23, 2026
NN-01-195, a Novel Conjugate of HSP90 and AURKA Inhibitors, Effectively Targets Solid Tumors.

Theodore T Nguyen, Nitesh K Nandwana, Yellamelli V V Srikanth

Pageof 5

Frequent Collaborators

6 joint publications

Robert L Ferris

5 joint publications

Nabil F Saba

4 joint publications

Amanda Psyrri

4 joint publications

Kevin J Harrington